^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG CLASS:

Dihydrofolic acid reductase inhibitor

2d
New P2 trial
|
methotrexate IV
2d
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis (clinicaltrials.gov)
P2, N=16, Recruiting, Wake Forest University Health Sciences | Trial primary completion date: Dec 2025 --> May 2026
Trial primary completion date
|
HER-2 (Human epidermal growth factor receptor 2) • ER (Estrogen receptor) • PGR (Progesterone receptor)
|
HER-2 positive • HER-2 negative • ER negative • HER-2 negative + AR positive + ER positive
|
methotrexate IV
4d
Apremilast ameliorates methotrexate-induced renal injury in rats: role of TLR4/NF-κB/P38 MAPK/caspase-3 and Nrf2/HO-1 signaling pathways. (PubMed, Naunyn Schmiedebergs Arch Pharmacol)
Co-treatment with APRE at 20 mg/kg/day for 21 days markedly improved all biochemical and pathological alterations evoked by MTX, demonstrating significant nephroprotective effects. Apremilast inhibits methotrexate's harmful effects on the kidneys by activating signaling cascades that include Nrf2/HO-1, while simultaneously downregulating TLR4/NF-κB/p38 MAPK/Caspase-3.
Preclinical • Journal • IO biomarker
|
BCL2 (B-cell CLL/lymphoma 2) • IL6 (Interleukin 6) • TNFA (Tumor Necrosis Factor-Alpha) • HMOX1 (Heme Oxygenase 1) • CASP3 (Caspase 3) • TLR4 (Toll Like Receptor 4) • RELA (RELA Proto-Oncogene)
|
methotrexate
4d
Tumor cell-derived microparticles induced by methotrexate reprogram neutrophil antitumor response via lysosomal ROS mediated degranulation. (PubMed, Mol Cancer Res)
By performing the combination of MTX-MP-activated neutrophils and OT-1 CD8+ T cells transfer, we found that the long-term survival rate improved in OVA-expressing Lewis lung carcinoma (LLC-OVA) models. Implications: Our findings revealed a new way by which activated-neutrophils release microparticles to kill tumor cells and provided a potential combinatorial therapeutic strategy for tumor immunotherapy.
Journal
|
CD8 (cluster of differentiation 8)
|
methotrexate
4d
Successful treatment of primary intramedullary spinal cord lymphoma based on the molecular diagnosis of a MYD88 mutation in the cerebrospinal fluid: a case report. (PubMed, Int Cancer Conf J)
Treatment with rituximab, high-dose methotrexate, and focal radiotherapy was initiated...Liquid biopsy of the CSF provides a promising alternative for diagnosing PISCL. However, further studies are needed to validate the clinical utility of this diagnostic approach.
Journal
|
MYD88 (MYD88 Innate Immune Signal Transduction Adaptor) • IL2 (Interleukin 2) • IL10 (Interleukin 10)
|
Rituxan (rituximab) • methotrexate • methotrexate IV
7d
Hesperidin methyl chalcone alleviates imiquimod-induced psoriasis in mice: effects alone and in combination with methotrexate. (PubMed, Naunyn Schmiedebergs Arch Pharmacol)
In conclusion, this study provides the first preclinical evidence that HMC, particularly in combination with MTX, ameliorates IMQ-induced psoriasis via modulation of inflammatory cytokines, oxidative stress, and histopathological damage. These findings suggest its potential as a therapeutic candidate that warrants further preclinical and clinical investigation in plaque-type psoriasis.
Preclinical • Journal
|
TNFA (Tumor Necrosis Factor-Alpha) • IL17A (Interleukin 17A)
|
methotrexate • Zyclara (imiquimod)
7d
The "Route Cause" of Methotrexate-Induced Brain Structure Changes in a Juvenile Mouse Model: Comparison of Systemic and CNS-Targeted Chemotherapy. (PubMed, Neurotoxicology)
Comparison of systemic and intrathecal delivery routes revealed that systemic MTX had a wider impact on brain morphology than did IT MTX treatment, particularly at clinically relevant doses of IT MTX. This finding provides important insight into the mechanisms that likely underlie MTX-induced neurotoxicity and focuses potential interventions on systemic toxicity.
Preclinical • Journal
|
TP63 (Tumor protein 63)
|
methotrexate
8d
BI26 More than skin deep: a case of eosinophilic fasciitis in a patient with relapsing-remitting multiple sclerosis. (PubMed, Br J Dermatol)
Her disease remains well controlled on methotrexate 15 mg once weekly. While the development of eosinophilic fasciitis in this case was presumed to be idiopathic, to our knowledge, this is the first case of eosinophilic fasciitis developing in the setting of long-term ocrelizumab use.
Journal
|
CRP (C-reactive protein)
|
methotrexate • Ocrevus (ocrelizumab)
8d
SG05 The use of oral methotrexate in a case of Ferguson-Smith syndrome. (PubMed, Br J Dermatol)
Despite 3 years of acitretin therapy, surgical excisions, imiquimod and repeated cryotherapy, the lesions remained poorly controlled. This case, along with her sister's experience, highlights oral methotrexate as a potential therapeutic option for refractory cases. Further studies are needed to explore its role in the management of this challenging condition.
Journal
|
TGFBR1 (Transforming Growth Factor Beta Receptor 1)
|
methotrexate • Zyclara (imiquimod)
8d
PA26 Folliculotropic mycosis fungoides with large cell transformation in an adolescent patient. (PubMed, Br J Dermatol)
He commenced first-line systemic therapy with methotrexate, but had no response. He was switched to brentuximab vedotin and has received eight cycles with partial response...Approach to mycosis fungoides in children: consensus-based recommendations. J Am Acad Dermatol 2024; 91: 1078-85).
Journal
|
CD8 (cluster of differentiation 8) • TNFRSF8 (TNF Receptor Superfamily Member 8) • CD4 (CD4 Molecule) • CD7 (CD7 Molecule) • SESN1 (Sestrin 1)
|
TNFRSF8 expression
|
methotrexate • Adcetris (brentuximab vedotin)
8d
BI33 Expect the unexpected. (PubMed, Br J Dermatol)
After not responding to topical treatments and apremilast, and experiencing short-term remission with phototherapy, he began treatment with methotrexate in consultation with rheumatologists...He was prescribed tamoxifen for the following 5 years...This research is crucial for the development of early detection and prevention strategies. Finally, patients diagnosed with melanoma should continue regular surveillance, not only for potential melanoma recurrence but also to detect new primary cancers.
Journal • BRCA Biomarker
|
BRCA2 (Breast cancer 2, early onset) • CDKN2A (Cyclin Dependent Kinase Inhibitor 2A)
|
tamoxifen • methotrexate
8d
P021 A case of radiation-induced haemorrhagic bullous lichen sclerosus of the breast. (PubMed, Br J Dermatol)
Her right breast ductal carcinoma, diagnosed 9 months prior, was treated with surgery, adjuvant letrozole and radiotherapy...Management options include topical and systemic corticosteroids, phototherapy and methotrexate (Hobbs L, Tiwari N. Hemorrhagic bullous lichen sclerosus of the breast: a rare complication of radiotherapy...To the best of our knowledge, this is the fifth reported case of RHBLS. Early recognition is crucial to alleviate concerns about breast cancer recurrence and to rule out vulval lichen sclerosus.
Journal
|
IL4 (Interleukin 4)
|
methotrexate • letrozole